Compare DexCom, Inc. (DXCM) vs Match Group Inc (MTCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Match Group Inc — how do they compare? DexCom, Inc. trades at $77.28 (market cap $28.06B), while Match Group Inc trades at $40.4 (market cap $9.36B). The key difference: DexCom, Inc. is far larger — about 3× Match Group Inc's market cap, and Match Group Inc pays a 1.99% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | MTCH | |
|---|---|---|
Market Cap | $28.06B | $9.36B |
Sector | Health | Media |
52-Week High | $89.53 | $40.11 |
52-Week Low | $54.84 | $28.90 |
Enterprise Value | $27.03B | $12.31B |
Dividend Yield | — | 1.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
MTCH trades at $40.71, up 6.18% in the last session, with a bullish technical signal and strong analyst support. The stock shows solid fundamentals with a P/E of 15.31, net income margin of 18.83%, and consistent earnings beats in recent quarters. Operating cash flow grew to $1.08B in 2025, while revenue remains stable at $3.49B. Recent news highlights Tinder's turnaround efforts and Hinge's growth, with Q2 2026 earnings due August 4, 2026.
The outlook is positive with a consensus price target of $41.63, implying modest upside. Risks include high long-term debt of $3.85B and declining Tinder users, offset by pricing power and AI features. Institutional sentiment is bullish with no sell ratings, but investors should monitor Q2 earnings for growth sustainability amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →
